Cisplatin-Induced Bradycardia: A Silent Risk Observed in Two Different Clinical Cases

Cisplatin is a platinum-containing drug that inhibits DNA synthesis by inhibiting cross-linking, denaturing DNA strands. It is used in combination with other chemotherapeutic agents to treat several types of cancers. Numerous adverse effects have been reported with this compound. However, it is cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Bin Naeem, Sameen, Azhar, Musa, Baloch, Naqib Ullah, Abbas, Mansoor, Waheed, Muhammad, Masood Sheikh, Rizwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686342/
https://www.ncbi.nlm.nih.gov/pubmed/34950548
http://dx.doi.org/10.7759/cureus.19769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686342/
https://www.ncbi.nlm.nih.gov/pubmed/34950548
http://dx.doi.org/10.7759/cureus.19769

Ejemplares similares